Výsledky vyhledávání

Akademický článek

Household contact management and preventive treatment for drug-resistant tuberculosis.

Autor: Seddon JA; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Department of Infectious Disease, Imperial College London, London W2 1PG, UK. Electronic address: james.seddon@imperial.ac.uk., McQuaid CF; TB Modelling Group, TB Centre and Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Mafirakureva N; Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Hesseling AC; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Fox GJ; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Dodd PJ; Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Sep; Vol. 12 (9), pp. e1387-e1388.

Zobrazit plný text záznamu

Akademický článek

Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study.

Autor: Morgan H; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Ndjeka N; National Department of Health, Tuberculosis Control and Management Cluster, Pretoria, South Africa., Hasan T; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Gegia M; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Mirzayev F; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Nguyen LN; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Schumacher S; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Schlub TE; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Naidoo K; Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa., Fox GJ; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1698-1706.

Zobrazit plný text záznamu

Akademický článek

High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial.

Autor: Ruslami R; Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Research Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung, Indonesia., Fregonese F; Montreal Chest Institute, Research Institute of the McGill University Health Center, Montreal, QC, Canada; McGill International TB Centre, McGill University, Montreal, QC, Canada., Apriani L; Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Research Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung, Indonesia., Barss L; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Bedingfield N; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Chiang V; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Cook VJ; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada., Fisher D; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Flores E; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Fox GJ; Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Woolcock Institute of Medical Research, Glebe, NSW, Australia., Johnston J; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada., Lim RK; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Long R; Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada., Paulsen C; Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada., Nguyen TA; Woolcock Institute of Medical Research, Glebe, NSW, Australia., Nhung NV; National Lung Hospital, VNU Ha Noi, Viet Nam; University of Medicine and Pharmacy, VNU Ha Noi, Viet Nam., Gibson D; McGill International TB Centre, McGill University, Montreal, QC, Canada., Valiquette C; Montreal Chest Institute, Research Institute of the McGill University Health Center, Montreal, QC, Canada; McGill International TB Centre, McGill University, Montreal, QC, Canada., Benedetti A; Montreal Chest Institute, Research Institute of the McGill University Health Center, Montreal, QC, Canada; McGill International TB Centre, McGill University, Montreal, QC, Canada., Menzies D; Montreal Chest Institute, Research Institute of the McGill University Health Center, Montreal, QC, Canada; McGill International TB Centre, McGill University, Montreal, QC, Canada. Electronic address: dick.menzies@mcgill.ca.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Jun; Vol. 12 (6), pp. 433-443. Date of Electronic Publication: 2024 Mar 26.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání